Evidence map›Paper›PMID 30286185›Full record

ArticlePloS one2018

Features of urinary Escherichia coli isolated from children with complicated and uncomplicated urinary tract infections in Mexico.

Víctor M Luna-Pineda, Sara A Ochoa, Ariadnna Cruz-Córdova, Vicenta Cázares-Domínguez, Juan P Reyes-Grajeda, Marco A Flores-Oropeza, José Arellano-Galindo, Rigoberto Hernández-Castro, Marcos Flores-Encarnación, Adriana Ramírez-Vargas and 3 more

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Curli of UropathogenicFrontiers in microbiology · 2019
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Víctor M Luna-PinedaLaboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México "Federico Gómez", CDMX, México.
Sara A OchoaLaboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México "Federico Gómez", CDMX, México.
Ariadnna Cruz-CórdovaLaboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México "Federico Gómez", CDMX, México.
Vicenta Cázares-DomínguezLaboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México "Federico Gómez", CDMX, México.
Juan P Reyes-GrajedaInstituto Nacional de Medicina Genómica, CDMX, México.
Marco A Flores-OropezaLaboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México "Federico Gómez", CDMX, México.
José Arellano-GalindoDepartamento de Infectología, Hospital Infantil de México "Federico Gómez", CDMX, México.
Rigoberto Hernández-CastroDepartamento de Ecología de Agentes Patógenos, Hospital General "Dr. Manuel Gea Gonzalez", CDMX, México.
Marcos Flores-EncarnaciónFacultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, México.
Adriana Ramírez-VargasFacultad de Biología, Benemérita Universidad Autónoma de Puebla, Puebla, México.
Héctor J Flores-GarcíaFacultad de Biología, Benemérita Universidad Autónoma de Puebla, Puebla, México.
Leticia Moreno-FierrosLaboratorio de Inmunidad en Mucosas, Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, Estado de México, México.
Juan Xicohtencatl-CortesLaboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México "Federico Gómez", CDMX, México.ORCID 0000-0003-2577-9973

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Hospital Infantil de México Federico Gómez (HIMFG) is a tertiary care hospital in Mexico City where Escherichia coli is frequently isolated from the urine samples of pediatric patients with urinary tract infections. A collection of 178 urinary Escherichia coli (UEc) isolates associated with complicated and uncomplicated urinary tract infections were evaluated in this study. The patterns of resistance to 9 antibiotic classes showed that 60.7% of the UEc isolates had a highly multidrug-resistant (MDR) profile. Genetic diversity analyses of the UEc isolates showed a high variability and revealed 16 clusters associated with four phylogenetic groups, namely, groups A, B1, B2, and D. Phylogenetic group B2 was widely associated with the 16 clusters as well as with virulence and fitness genes. The virulence and fitness genes in the UEc isolates, which included fimbriae-, siderophore-, toxin-, and mobility-associated genes, were grouped as occurring at a low, variable, or high frequency. Interestingly, only the papF gene could be amplified from some UEc isolates, and the sequence analysis of the pap operon identified an insertion sequence (IS) element and gene loss. These data suggested pathoadaptability and the development of immune system evasion, which was confirmed by the loss of P fimbriae-associated agglutination in the UEc isolates. E. coli clone O25-ST131 had a prevalence of 20.2% among the UEc isolates; these isolates displayed both a highly MDR profile and the presence of the papGII, fimH, papGIII, iutD, sat, hlyA, and motA genes. In conclusion, the UEc isolates from complicated urinary tract infection (cUTI) were characterized as being MDR, highly genetically diverse, and associated with phylogenetic group B2 and many virulence and fitness genes. Additionally, gene loss and IS elements were identified in some UEc isolates identified as clone O25-ST131.

Indexed as

Anti-Bacterial AgentsChildDrug Resistance, BacterialEscherichia coliFemaleGenetic LociGenetic VariationHumansINDEL MutationMaleMexicoPhylogenyUrinary Tract InfectionsVirulenceAnti-Bacterial Agents

Identifiers

PMID30286185
PMCPMC6171886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.